Custom Synthesis

Introduction The immunogenicity of peptide-oligonucleotide conjugates is a multifaceted biological phenomenon resulting from the synergistic interplay of immunogenic peptide epitopes, […]

Introduction: Peptide-Oligonucleotide Conjugates in Gene Silencing applications have emerged as one of the most technically sophisticated and clinically promising strategies

Introduction Antisense Oligonucleotide-Peptide Conjugates have emerged as an advanced therapeutic platform designed to address the longstanding pharmacokinetic, biodistribution, and intracellular

Introduction Cell-Penetrating Peptides in Oligonucleotide Conjugates are sophisticated chimeric macromolecules developed to address the significant challenge of poor cellular uptake

Introduction Peptide-oligonucleotide conjugates (POCs) demand tightly controlled chemical, thermal, and physical conditions to preserve their structural integrity and biological functionality

Introduction: The immunogenicity of peptide-oligonucleotide conjugates is one of the most consequential development risks facing sponsors working with this rapidly

Introduction to Peptide-Oligonucleotide Conjugates Specification Setting Peptide-Oligonucleotide Conjugates Specification Setting is the systematic process of establishing scientifically justified physical, chemical,

Introduction: A receptor-targeted peptide oligonucleotide conjugate (POC) is an engineered biotherapeutic that links an antisense oligonucleotide (ASO) payload to a

Introduction to Regulatory Expectations for Peptide-Oligonucleotide Conjugates in IND Submissions The regulatory pathway for advancing Peptide-Oligonucleotide Conjugates (POCs) in Investigational

Introduction The successful clinical development and regulatory approval of hybrid biotherapeutics depend on advanced analytical strategies for the Structural Characterization